Naproxen for Acute Gout
For acute gout, start naproxen at 750 mg immediately, followed by 250 mg every 8 hours until the attack resolves, ideally initiated within 36 hours of symptom onset. 1
Dosing Regimen
The FDA-approved dosing for acute gout is specific and straightforward 1:
- Initial dose: 750 mg naproxen
- Maintenance: 250 mg every 8 hours
- Continue until: The acute attack has completely subsided
This regimen is supported by both FDA labeling 1 and clinical trial evidence demonstrating efficacy comparable to other NSAIDs 2, 3. The higher loading dose provides more rapid symptom relief compared to lower initial dosing 4.
Duration of Treatment
Continue naproxen at full dose until the gouty attack has completely resolved 5. Do not taper prematurely—the attack must be fully suppressed before discontinuation. This typically ranges from several days to 1-2 weeks depending on attack severity.
Timing Considerations
Initiate treatment within 36 hours of symptom onset for optimal efficacy 5. Earlier treatment (ideally within 12 hours) produces better outcomes 6. Patients should be educated to self-medicate at the first sign of an attack using a pre-defined treatment plan.
Contraindications and High-Risk Populations
Naproxen is contraindicated or requires extreme caution in patients with 7:
- Renal disease: Avoid in moderate-to-severe renal impairment (creatinine clearance <30 mL/min) 1
- Heart failure: NSAIDs can precipitate decompensation
- Cirrhosis: Increased bleeding risk and fluid retention
- Active peptic ulcer disease or GI bleeding history: High risk of perforation, ulcers, and bleeding 7
- Concurrent anticoagulation: Significantly increases bleeding risk
Dose Adjustments
- Elderly patients: Use lowest effective dose due to increased unbound drug fraction 1
- Hepatic impairment: Consider dose reduction 1
- Mild renal impairment: Consider dose reduction, but avoid entirely if CrCl <30 mL/min
Alternative First-Line Options
The 2017 ACP guidelines actually recommend considering corticosteroids as first-line therapy over NSAIDs due to superior safety profile 7. This represents a shift from older guidelines:
- Prednisolone 35 mg daily for 5 days is equally effective as NSAIDs with fewer adverse events 7, 8, 9
- Corticosteroids significantly reduce risk of indigestion (RR 0.50), nausea (RR 0.25), and vomiting (RR 0.11) compared to NSAIDs 9
- Colchicine (1.2 mg then 0.6 mg one hour later) is also first-line if started within 36 hours 5, 7
Clinical Pearls and Pitfalls
Common pitfalls to avoid:
- Don't use indomethacin preferentially—despite tradition, there is no evidence it's more effective than naproxen or other NSAIDs 7
- Don't underdose—the 750 mg loading dose is critical for rapid response 1, 4
- Don't stop too early—continue until complete resolution, not just improvement 5
- Don't ignore contraindications—NSAIDs cause significant morbidity in high-risk patients; choose corticosteroids instead 7, 9
For patients with multiple comorbidities (renal disease, heart failure, diabetes, hypertension): Strongly consider corticosteroids or colchicine as first-line instead of naproxen 7. The 2017 ACP guidelines emphasize that corticosteroids are "generally safer" with comparable efficacy 7.
Prophylaxis During Urate-Lowering Therapy
If the patient will be starting or is on urate-lowering therapy, low-dose naproxen 250 mg twice daily (with PPI if indicated) can be used for prophylaxis as a second-line option after colchicine 5.